Pharmaceutical vs talking therapies for stress, depression and anxiety

It is believed that as many as 1 in 4 people in the UK experience a mental health problem every year, with the British 7-year study predicting an average incidence of 3.3 people with clinical anxiety per 100 people in the workforce – yet this amount may be greater owing to individuals who do not report or report. Indeed, the World Health Organization says depression is the world's leading cause of ill health and disability, yet the reluctance in common culture to discuss adverse mental states continues. Depression, when defined, is described as an ongoing mood disorder that for several months provides constant emotions of sorrow, loss, suicidal thinking, hopelessness, and low mood, away from ordinary, typically more fleeting mood conditions.

Despite significant activism by mental health proponents and charities, females are more likely to be diagnosed with anxiety-related illnesses, yet men's suicide rate is greater than ever, with suicide ranked as the leading cause of death for men aged 20-34. A complicated variety of societal, psychological and behavioural elements seems to be related to the variations in mental health issues experienced by males and females, with depression having even transgender people much more prevalence. Below, we will assess the depression treatments and look at the proof that supports these therapies.

The long-prescribed antidepressant drugs are frequently of two groups: tricyclic antidepressant (TCA) and serotonin reuptake (SSRI) inhibitors. As the name indicates, these medications operate by stopping the reuptake of the compound to boost the accessibility of serotonin in the brain. Serotonin is an archaic molecule that controls cognition, excitement, reward and many other complicated physiological procedures in the body and exists in numerous animals, all the way to marine creatures and easy invertebrates, indicating that it has been engaged in natural life for millions of years. In many species, including humans, serotonin is believed to exist in an inherent' reward system' whereby processes and behaviours that benefit survival boost the expression of dopamine and serotonin in the organism, providing positive feedback and a reward for' feel good.'

The expression of serotonin among other neurotransmitters is believed to be influenced in depressed people, leading to decreases in ordinary physiological concentrations at synapses in the brains of depressed people, resulting in reduced mood, arousal and persistent bad moods. Over the years, TCA and SSRI have been introduced many times, with the latter class of antidepressants being the current first.

In people who visit their GP with symptoms of moderate to severe depression, the first line treatment is CBT and a CBT plus antidepressant simultaneously, yet it is always up to the patient to assess the hazards and advantages of these methods. Typically, antidepressant medication has an excellent safety profile and is well tolerated by many people, but the time to relieve depression symptoms is at least 6 weeks. The nature of the drug involves a complicated physiological process that requires time to get a decent quantity of the drug in the blood (called half-life). This impacts the time it takes for people to feel better, with some people having a range of reactions and unknown efficacy. In people under the age of 25, antidepressant medication comes with a black box warning of the danger of enhanced suicidal ideology and thought owing to modifications in brain chemistry with this medication.

Large meta-analysis (the strongest form of scientific evidence assessment) usually discovered excellent outcomes with antidepressant drugs for general depression and clinical depression, with a range of reaction times ranging from 12 weeks to 2 years all demonstrating excellent symptom relief. It is recognized, however, that depression can be a refractory disease, thus further investigating the connection between withdrawal from antidepressant medication and the recurrent onset of depressive periods. Interestingly, antidepressant drugs often operate better in depression of higher severity, with big meta-analysis finding negligent difference in mild depression compared to placebo pills. Medication as a prophylaxis strategy is appealing, as the use of dual treatment methods can help people from a physiological and psychological view.

After about 6 weeks, the side effects of antidepressants such as fatigue, brain fog, gastrointestinal distress and mood swings usually subside, but greater doses prevent people from having quite significant sexual side effects such as absence of excitement, failure to retain erections, dryness and absence of secretions (in women) and low libido. Indeed, the earlier reflected concept of blended treatment methods is of concern in a time when over prescription of these drugs is a burden on secondary health results and health care providers, and other treatments such as speaking therapies can play a part in the behavioural elements of depression.

Talking therapies such as cognitive behavioural therapy (CBT) are methods used in patients with depression and other mood disorders by counsellors and psychologists to challenge unhelpful behaviours and ideas. This method seeks to rationalize and challenge thinking and behaviour patterns to allow the person to alter their perspective with self-actualization and empowerment. Psychotherapy such as CBT uses conceptualization of the strengths and weaknesses of the individual and defines fields to be explored. For instance, a person may be great at vocalizing their issues and problems to friends but may suffer from patterns of thinking such as catastrophic (assuming the worst and thinking of the worst-case scenario in circumstances).

The therapist and person can operate synergistically in fields such as self-esteem, making friends, altering habits, and challenging unhealthy interactions by offering social support and a lifeline to speak to. On the NHS, it can sometimes be long waiting times for talking therapies, which can be inappropriate for people with severe depression. Hence, these people are often referred directly as an instant treatment reaction to antidepressant drugs. However, therapy of physiological inadequacies leading to depression can sometimes be redundant without first addressing unhelpful thinking patterns, so therapy must require a mixture of these two methods is often seen. Another large-scale assessment with over 100,000 respondents discovered that those with mild depression experienced equal relief with talk therapies and antidepressant medication, reinforcing the use of these methods.

At Working Well, we primarily support decisions made by healthcare professionals as they have the correct jurisdiction to make health-based decisions around care and treatment. However, we often advocate well for talking therapies and counselling – not because we just offer those services – but because these techniques address the primary causes of psychological distress. Tackling the causes and working through difficult emotions – be that workplace stress or relationship issues – is vital to prevent relapses in depressive symptoms which happen sometimes on cessation of drug therapy. Much of the modern world approach to tackling psychological issues arise at treating the symptoms but leave individuals vulnerable and resistant to further personal growth due to an absence of attention on the fundamental factors.

In the United Kingdom, the use of antidepressant medication may be heavily transferred in case of mild depression where more efficient speaking therapies may be found. However, in conjunction with talk therapies, people with serious depressive disorders are excellent candidates for antidepressant medication. Individuals need to be informed by their clinician of the spectrum of side effects of medication as this dramatically impacts the capacity for treatment retention and adherence to therapy plans. Future studies and research should aim to further assess the most efficient types of therapy for various types of depression and use in distinct genders, backgrounds and ethnicities. In addition, awareness campaigns should caution people about the side effects of drugs but stress their relatively good safety tolerance profiles to alleviate depressive symptoms.

21 views0 comments

Copyright WorkingWell Limited 2019. 80 Fleet Street, London, EC4Y 1ET.